On February 21, the FDA directed all manufacturers of stimulants to develop Medication Guides for patients, spelling out, in non-technical language, the dan- gers of taking these medications. Last year, the FDA required an additional black box warning for stimulants warning of the risk of sudden death due to cardiac complications. This new directive responds to concerns that the black box information wasn’t filtering down to consumers. You can view the drafts of these medication guides at http://www.fda.gov/cder/ drug/infopage/ADHD/default.htm. Don’t worry, you won't have to keep a stack of these in your office; the pharmacist who fills the script will hand them to your patients.
TCPR’s Take: This will certainly leadto many questions from patients and family members, as well as fewer stimulant prescriptions overall – which is either a good or a bad thing depending on your pharmaco-politics. Some psychiatrists believe that ADHD is severely under-treated, while others believe that the current wave of stimulant enthusiasm has gone overboard. You can find research data to support either position if you look hard enough!
PO Box 626, Newburyport MA 01950